An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs - PubMed (original) (raw)
. 1999 May 1;248(2):457-72.
doi: 10.1006/excr.1999.4433.
Affiliations
- PMID: 10222137
- DOI: 10.1006/excr.1999.4433
An inhibitor of nuclear export activates the p53 response and induces the localization of HDM2 and p53 to U1A-positive nuclear bodies associated with the PODs
S Laín et al. Exp Cell Res. 1999.
Abstract
Leptomycin B is a cytotoxin which directly interacts with and inhibits the action of CRM1, an essential mediator of the nuclear exit of proteins containing nuclear export signals (NES) of the HIV1 REV type. We show that addition of leptomycin B to human primary fibroblasts increased the levels of the p53 tumor suppressor protein. This was accompanied by the induction of p53-dependent transcriptional activity in cultured cells and an increase in the levels of the products of two p53-responsive genes, the p21(CIP1/WAF1) and HDM2 proteins. Leptomycin B induced the accumulation of p53 and HDM2 in the nucleus and the appearance of discrete nuclear aggregates containing both proteins. It has been reported that the transcriptional activity of p53 is modulated by its interaction with the HDM2 protein which also targets p53 for rapid degradation. Using a model cell line conditionally expressing MDM2, the murine analogue of HDM2, we present evidence indicating that leptomycin B abrogates MDM2's role in p53 degradation and that the accumulation of p53 in distinct nuclear bodies is mediated by MDM2. Since HDM2 has recently been shown to contain a functional NES of the REV type, the most likely explanation for our results is that the effect of leptomycin B on HDM2 and p53 is due to the inhibition of nuclear export. The ability to visualize sites where p53 and HDM2 colocalize provides a new approach to study the association between the two proteins in vivo. These p53/HDM2-positive nuclear foci were found to also contain the U1A snRNP A and to be juxtaposed to the PML oncogenic domains.
Copyright 1999 Academic Press.
Similar articles
- Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6.
Freedman DA, Levine AJ. Freedman DA, et al. Mol Cell Biol. 1998 Dec;18(12):7288-93. doi: 10.1128/MCB.18.12.7288. Mol Cell Biol. 1998. PMID: 9819415 Free PMC article. - Activation of p53 in cervical carcinoma cells by small molecules.
Hietanen S, Lain S, Krausz E, Blattner C, Lane DP. Hietanen S, et al. Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8501-6. doi: 10.1073/pnas.97.15.8501. Proc Natl Acad Sci U S A. 2000. PMID: 10900010 Free PMC article. - Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein.
Roth J, Dobbelstein M, Freedman DA, Shenk T, Levine AJ. Roth J, et al. EMBO J. 1998 Jan 15;17(2):554-64. doi: 10.1093/emboj/17.2.554. EMBO J. 1998. PMID: 9430646 Free PMC article. - Nucleophosmin, HDM2 and p53: players in UV damage incited nucleolar stress response.
Kurki S, Peltonen K, Laiho M. Kurki S, et al. Cell Cycle. 2004 Aug;3(8):976-9. Epub 2004 Aug 8. Cell Cycle. 2004. PMID: 15254398 Review. - Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists.
Kocik J, Machula M, Wisniewska A, Surmiak E, Holak TA, Skalniak L. Kocik J, et al. Cancers (Basel). 2019 Jul 19;11(7):1014. doi: 10.3390/cancers11071014. Cancers (Basel). 2019. PMID: 31331108 Free PMC article. Review.
Cited by
- An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells.
van Leeuwen IM, Rao B, Sachweh MC, Laín S. van Leeuwen IM, et al. Cell Cycle. 2012 May 1;11(9):1851-61. doi: 10.4161/cc.20254. Epub 2012 May 1. Cell Cycle. 2012. PMID: 22517433 Free PMC article. - Chemotherapeutic sensitization of leptomycin B resistant lung cancer cells by pretreatment with doxorubicin.
Lu C, Shao C, Cobos E, Singh KP, Gao W. Lu C, et al. PLoS One. 2012;7(3):e32895. doi: 10.1371/journal.pone.0032895. Epub 2012 Mar 7. PLoS One. 2012. PMID: 22412944 Free PMC article. - Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2.
Salcedo A, Mayor F Jr, Penela P. Salcedo A, et al. EMBO J. 2006 Oct 18;25(20):4752-62. doi: 10.1038/sj.emboj.7601351. Epub 2006 Sep 28. EMBO J. 2006. PMID: 17006543 Free PMC article. - Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells.
Mesaeli N, Phillipson C. Mesaeli N, et al. Mol Biol Cell. 2004 Apr;15(4):1862-70. doi: 10.1091/mbc.e03-04-0251. Epub 2004 Feb 6. Mol Biol Cell. 2004. PMID: 14767071 Free PMC article. - Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.
Chehab NH, Malikzay A, Appel M, Halazonetis TD. Chehab NH, et al. Genes Dev. 2000 Feb 1;14(3):278-88. Genes Dev. 2000. PMID: 10673500 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous